USANA Health Sciences (USNA) Misses Q3 EPS by 71c, provides guidance
Tweet
Share
E-mailGet Alerts USNA Hot Sheet
Price: $21.09 +1.88%
EPS Growth %: -41.9%
Financial Fact:
Net sales: 254.22M
Today's EPS Names:
DTGI, OCCI, MAYS, More
EPS Growth %: -41.9%
Financial Fact:
Net sales: 254.22M
Today's EPS Names:
DTGI, OCCI, MAYS, More
Join SI Premium – FREE
USANA Health Sciences (NYSE: USNA) reported Q3 EPS of ($0.15), $0.71 worse than the analyst estimate of $0.56. Revenue for the quarter came in at $214 million versus the consensus estimate of $224.97 million.
GUIDANCE:
USANA Health Sciences sees FY2025 EPS of $0.78, versus the consensus of $1.70. USANA Health Sciences sees FY2025 revenue of $920 million, versus the consensus of $919.6 million.
For earnings history and earnings-related data on USANA Health Sciences (USNA) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Carlisle Made Unsolicited Offers for Rival Owens Corning - WSJ
- Citi Downgrades EasyJet Plc. (EZJ:LN) (ESYJY) to Neutral
- Viridian Therapeutic (VRDN) PT Raised to $43 at Wedbush
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
